Compare HFBL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFBL | MBOT |
|---|---|---|
| Founded | 1924 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.0M | 73.2M |
| IPO Year | 2010 | 2000 |
| Metric | HFBL | MBOT |
|---|---|---|
| Price | $22.37 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 3.7K | ★ 794.6K |
| Earning Date | 10-27-2026 | 11-20-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 60.32 | 60.27 |
| EPS | ★ 2.02 | N/A |
| Revenue | ★ $1,694,000.00 | $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | $11.06 | ★ N/A |
| Revenue Growth | ★ 30.01 | N/A |
| 52 Week Low | $14.47 | $0.93 |
| 52 Week High | $28.00 | $2.86 |
| Indicator | HFBL | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 50.72 |
| Support Level | $21.08 | N/A |
| Resistance Level | $23.87 | $1.18 |
| Average True Range (ATR) | 0.81 | 0.07 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 47.08 | 70.00 |
Home Federal Bancorp Inc of louisiana operates as a bank holding company. Through its subsidiary, a federally chartered stock savings bank, it provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial, and multi-family segments. The company also invests in securities held-to-maturity and securities available for sale.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.